● ImportantWorld3 outlets covering this

Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks

First publishedAug 20, 11:22 UTC
Last updatedAug 21, 00:22 UTC · 5m ago
11 outletSeattle Times11 outletAl Jazeera11 outletPBS NewsHour
3 outlets over time — hover a bar for its window & outletslast updated
● Story signals

How strong is this topic?

7.5/10Significanceimpact & urgency
7.0/10Source trustoutlet authority
3Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

WHO said in a statement that while it's not known whether Ervebo may protect against the Bundibugyo virus, "early laboratory and animal data suggest it may provide some protection."

Reported by 3 outlets PBS NewsHour, Al Jazeera, Seattle Times. See all sources ↓

Read the full report at PBS NewsHour

Why it matters

3 outlets are covering this world story — one to watch as reporting develops.

In brief
What's the story?
WHO said in a statement that while it's not known whether Ervebo may protect against the Bundibugyo virus, "early laboratory and animal data suggest it may provide some protection."
How widely is it covered?
3 outlets, average source rating 7.0/10.
When was it last updated?
5m ago.
Different angles across outlets
Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

  • Coverage card3 outlets
    1Coverage
    Scouting report

    Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

    Sources3
    TypeCoverage
    PBS NewsHour
    Al Jazeera
    Seattle Times
Related in the knowledge graph
Sources (3)
Avg source rating 7.0/10
Processing cluster
A1A2A3B1B2B3
Share this article
Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)